The board of directors of Medivir AB 's statement under Chapter 19 Section 22 of the Swedish Companies Act
The board of directors has proposed that the annual...
Nov 03, 2022 / 02:00PM GMTOperator Welcome to the Medivir Q3 2022 Report. (Operator Instructions) I'll now hand you over to the CEO, Jens Lindberg. Please begin
Apr 28, 2022 / 01:00PM GMTOperator Hello, and welcome to the Medivir Audiocast Teleconference Q1 2022. (Operator Instructions) Today, I'm pleased to have CEO, J
Feb 15, 2022 / 01:00PM GMTOperator Ladies and gentlemen, welcome to the Medivir Audiocast Teleconference for Q4 2021. (Operator Instructions) Today, I am please
Nov 03, 2021 / 02:00PM GMTOperator Ladies and gentlemen, welcome to the Medivir AB Q3 Report 2021. (Operator Instructions) Today, I am pleased to present Magnus
Sep 16, 2021 / 01:00PM GMTOperator Welcome to the Medivir Conference entitled News Supporting Clinical Data and Further Studies with MIV-818. (Operator Instruct
Aug 19, 2021 / 12:00PM GMTOperator Hello, and welcome to the Medivir AB Q2 Report 2021. (Operator Instructions) Today, I am pleased to present Magnus Christense
Apr 28, 2021 / 12:00PM GMTOperator Ladies and gentlemen, welcome to the Medivir AB Q1 Report 2021. (Operator Instructions) Today, I'm pleased to present Yilmaz
/PRNewswire/ -- Promising clinical results, successful business development and secured financing October - December Financial summary for the quarter Net...
AUSTIN, Texas, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for ...
Medivir AB (MVIR)announces that it has entered into a license agreement with Ubiquigent for the company's preclinical USP7 research program.Under the terms of the agreement, Medivir...
HUDDINGE, Sweden, Feb. 7, 2021 /PRNewswire/ -- The Board of Directors in Medivir AB has decided to summon an extraordinary general meeting on 11 March 2021 to propose a directed issue to the...
/PRNewswire/ -- The Board of Directors in Medivir AB (publ) ("Medivir" or the "Company") has decided to summon an extraordinary general meeting on 11 March...